thiazolyl blue has been researched along with 5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitch, BA; Fruman, DA; Janes, MR; Lee, JS; Mallya, S; So, L | 1 |
1 other study(ies) available for thiazolyl blue and 5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine
| Article | Year |
|---|---|
Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Benzoxazoles; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Drug Resistance; Gene Knockdown Techniques; Humans; Lymphoma; Phosphoproteins; Pyrimidines; Tetrazolium Salts; Thiazoles; TOR Serine-Threonine Kinases | 2014 |